Drug class
Selective phosphodiesterase-3 (PDE3) inhibitor; inodilator
Mechanism of action
Inhibits cardiac and vascular phosphodiesterase-3, increasing intracellular cyclic AMP. This produces positive inotropic activity and vasodilation, reducing cardiac loading conditions.
General use cases
- Short-term intravenous inotropic support in severe congestive heart failure in settings and jurisdictions where enoximone is available; not a routine long-term heart-failure therapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
